BiotechTube

ENMD-2076

Phase 2Completed
0 watching 0 views this week⚡ Active
44
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Ovarian Cancer

Conditions

Ovarian Cancer, Fallopian Cancer, Peritoneal Cancer

Trial Timeline

Apr 1, 2010 → Dec 1, 2012

NCT ID
NCT01104675

About ENMD-2076

ENMD-2076 is a phase 2 stage product being developed by CASI Pharmaceuticals for Ovarian Cancer. The current trial status is completed. This product is registered under clinical trial identifier NCT01104675. Target conditions include Ovarian Cancer, Fallopian Cancer, Peritoneal Cancer.

Hype Score Breakdown

Clinical
17
Activity
12
Company
2
Novelty
5
Community
5

Clinical Trials (6)

NCT IDPhaseStatus
NCT02234986Phase 2Completed
NCT01639248Phase 2Completed
NCT01104675Phase 2Completed
NCT00904787Phase 1Completed
NCT00806065Phase 1Completed
NCT00658671Phase 1Completed

Competing Products

20 competing products in Ovarian Cancer

See all competitors
ProductCompanyStageHype Score
azenosertibZentalis PharmaceuticalsPhase 2
44
Azenosertib + NiraparibZentalis PharmaceuticalsPhase 1/2
33
pemetrexed + topotecanEli LillyPhase 1
33
arzoxifene hydrochlorideEli LillyPhase 2
52
LY4337713Eli LillyPhase 1
33
PrexasertibEli LillyPhase 2
52
Durvalumab + BA3011 + BA3021 + ENB003 + ToripalimabBioAtlaPhase 2
44
Gemcitabine + Oxaliplatin + BevacizumabEli LillyPhase 2
52
Raludotatug Deruxtecan + Carboplatin + Paclitaxel + Bevacizumab + Rescue Medication + PembrolizumabDaiichi SankyoPhase 1/2
41
Trastzumab Deruxtecan + Bevacizumab + Platinum Based ChemotherapyDaiichi SankyoPhase 2
52
Trastuzumab Deruxtecan + BevacizumabDaiichi SankyoPhase 3
77
Trastuzumab deruxtecanDaiichi SankyoPhase 2
52
Trastuzumab deruxtecanDaiichi SankyoPhase 2
52
CS-1008 + Paclitaxel + CarboplatinDaiichi SankyoPhase 2
52
OSI-906 + PaclitaxelAstellas PharmaPhase 1/2
41
Enzalutamide 40 MGAstellas PharmaPhase 2
52
ASP0739Astellas PharmaPhase 1/2
41
IMAB027Astellas PharmaPhase 1
33
OSI-211 (Liposomal Lurtotecan)Astellas PharmaPhase 2
52
Triptorelin for Injection + Recombinant Human Choriogonadotropin alfa Solution for Injection + Progesterone Soft CapsulesSun PharmaceuticalPhase 3
77

Other Products from CASI Pharmaceuticals

Melphalan Hydrochloride for InjectionApproved
77
Panzem NCD + TemozolomidePhase 2
44
MKC-1Phase 2
44
Panzem (2-methoxyestradiol) NCD, Avastin (Bevacizumab)Phase 2
44
Panzem Nanocrystal Colloidal Dispersion (NCD)Phase 2
44